Medicine treats tumor clearance like a clean break, but that’s a fantasy. Once the infusion ends, the body doesn't just reset to baseline. We’re currently running a scorched-earth policy and ignoring the metabolic bill that comes due a decade later. Mechanistically, chemotherapy and high-dose radiation are the ultimate triggers for systemic ferroptosis. By flooding the system with pro-oxidant stressors to shatter malignant DNA, we’re simultaneously burning out the GPX4 defense systems in healthy vascular and neural tissue. It’s more than killing cancer; we’re inducing systemic rust.

The survivors are cancer-free, sure, but they’re walking around with a lipid peroxidation burden that mimics advanced senescence. We’ve known for years that survivors of childhood leukemias age biologically at twice the rate of their peers. It's time to stop treating this as a side effect and recognize it as a primary failure of the intervention. When we induce massive cell death, we release a tidal wave of labile iron and reactive aldehydes. This doesn't just dissipate. It triggers an epigenetic drift that effectively ages a survivor by fifteen years in a single treatment course. We’re trading a local malignancy for a global collapse of proteostasis and lipid integrity.

I want to know if this damage is a prerequisite for the cure or just a preventable tax. Why aren't we co-administering radical-trapping antioxidants or selective iron chelators as a standard of care? Maybe we’re afraid of protecting the tumor, or maybe we’re just too focused on the five-year survival window to worry about the fifteen-year neurodegenerative cliff. We need high-resolution funding for longitudinal lipidomic mapping in cancer survivors. Oncology and longevity shouldn't be separate departments. If we save a life only to hand it over to early-onset frailty, I don't think we've actually won. I'm looking for collaborators who want to bridge this gap. Let’s figure out how to shield the healthy membrane while the storm passes.